Grool, AM, van der Graaf, Y, Mali, WPTM, Geerlings, MI (2011 a). Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study. Journal of Neurology, Neurosurgery and Psychiatry 82, 1093–1100.
Grool, AM, van der Graaf, Y, Mali, WP, Witkamp, TD, Vincken, KL, Geerlings, MI (2011 b). Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: The Second Manifestations of ARTerial disease (SMART)-Medea study. Psychological Medicine. Published online: 11 August 2011. doi:10.1017/S0033291711001383.
Kroenke, K, Spitzer, RL, Williams, JB (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 16, 606–613.
Lodder, J (2007). Size criterion for lacunar infarction. Cerebrovascular Diseases 24, 156.
Muller, M, Grobbee, DE, Aleman, A, Bots, M, van der Schouw, YT (2007). Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 190, 143–149.
Potter, GM, Marlborough, FJ, Wardlaw, JM (2011). Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke 42, 359–366.
Sakthiswary, R, Das, S (2011). Location and progression of white-matter lesions, lacunar infarcts and atrophy associated with motivational and mood symptoms in patients with symptomatic atherosclerotic disease: things to ponder [Letter]. Psychological Medicine. doi:10.1017/S0033291711002285.
Thombs, BD, Ziegelstein, RC, Whooley, MA (2008). Optimizing detection of major depression among patients with coronary artery disease using the Patient Health Questionnaire: data from the Heart and Soul Study. Journal of General Internal Medicine 23, 2014–2017.